startup
Sofinnova Partners
A European venture capital firm specializing in life sciences and medtech investments.
- 机会评分
- 85 / 100
- 累计融资
- unknown
- 融资阶段
- unknown
- 成立年份
- unknown
- 地区
- Global
- 阶段
- unknown
八个维度
Company · Problem · Solution · Target Customer · Business Model · Funding · Competitors · Why NowCompany
Sofinnova Partners is a venture capital firm focused on life sciences and medical technologies. They recently closed an oversubscribed €82 million fund for medtech investments.
Problem
The firm identifies gaps in medtech innovation and seeks to support early-stage companies addressing unmet medical needs.
Solution
Through their specialized funds, Sofinnova Partners provides capital and expertise to medtech startups, fostering innovation in healthcare.
Target Customer
Early-stage medtech companies seeking venture capital funding.
Business Model
Revenue generated through equity investments in portfolio companies and realized gains upon exits.
Funding
Closed a €82 million medtech fund in 2026.
Competitors
Other European life sciences VCs like Balderton Capital and M Ventures.
Why Now
Growing interest in medtech innovation and increasing healthcare needs drive demand for specialized VCs.
来源与 AI 标注
模型 · prompt 版本 · 生成时间 · 来源链接相关项目与同赛道
按赛道继续看相关项目4 家
| 公司 | 赛道 | 评分 |
|---|---|---|
| Sofia-based LAUNCHub VenturesVenture capital firm targeting €75M+ Fund III | Venture CapitalFundraising | 90 |
| Sofinnova PartnersLife sciences investor focused on MedTech | MedTechLife SciencesVenture Capital | 85 |
| DIG VenturesInvesting in Europe's AI infrastructure startups | Venture CapitalAIEuropean Tech | 80 |
| Eureka! VentureDeepTech investment fund in Italy | DeepTechVenture CapitalItaly | 70 |
同赛道入口按赛道继续看
数据来自公开渠道与 AI 解读，仅供参考，不构成投资建议。信息可能滞后或有误，决策请以公司官网与官方披露为准。